Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted descending | Why surfaced |
|---|---|---|---|---|---|---|---|
| NLNHYOTC | Synd Energy Utilities | $65M | $0.3M/d | 0 | no coverage | 89 | Bookings disclosure expanded; consensus model still references the prior format. |
| USCSPNYSE | Orval Gas Utilities | $449M | $0.7M/d | 0 | no coverage | 83 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| QEUJTNYSE | Conduit Water Utilities | $280M | $1.2M/d | 0 | no coverage | 82 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| EBRWNYSE | Xander Steel Materials | $288M | $1.7M/d | 0 | no coverage | 81 | Channel structure obscures sell-through; alt-data flags acceleration. |
| AZDCOTC | Halcyon Energy Utilities | $425M | $0.9M/d | 0 | no coverage | 81 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| WSGFOTC | Junos Bio Healthcare | $282M | $1.2M/d | 0 | no coverage | 80 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| ZEBRNYSE | Zebra Steel Wire Materials | $96M | $0.3M/d | 0 | no coverage | 79 | Sub-$100M cap, OEM concentration overstated by sell-side that no longer covers. |
| DPUMCOTC | Penna Therapeutics Healthcare | $466M | $1.8M/d | 0 | no coverage | 79 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| RUPMOTC | Ember Diagnostics Healthcare | $256M | $0.5M/d | 0 | no coverage | 78 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| AFVVOTC | Drayve Therapeutics Healthcare | $72M | $0.5M/d | 1 | low coverage | 72 | Capacity-utilization step-up not present in the prior analyst note's model. |
| ATLSNYSE | Atlas Cement Holdings Materials | $612M | $2.1M/d | 2 | low coverage | 64 | Two-coverage cohort, regional infrastructure spend re-rates input prices not yet reflected. |
| NCYTSOTC | Penna Health Healthcare | $293M | $0.9M/d | 1 | low coverage | 64 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| NMARNYSE | Vante Materials Materials | $79M | $0.1M/d | 1 | low coverage | 63 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| GRMCNYSE | Granite Mountain Copper Materials | $412M | $1.8M/d | 2 | low coverage | 60 | Permitted expansion finalized post last analyst update; LOM extension materially understated. |
| XPFAUOTC | Quor Materials Materials | $90M | $0.2M/d | 4 | covered | 44 | Permitted expansion finalized after the last analyst update; LOM extension understated. |